Manolis Theodora A, Manolis Antonis A, Manolis Antonis S
Department of Psychiatry, Aiginiteio University Hospital, Athens, Greece.
Department of Int. Medicine, Elpis General Hospital of Athens, Athens, Greece.
Curr Vasc Pharmacol. 2025;23(3):172-195. doi: 10.2174/0115701611328094241104062903.
INTRODUCTION/OBJECTIVE: Emotional, mental, or psychological distress, defined as increased symptoms of depression, anxiety, and/or stress, is common in patients with chronic diseases, such as cardiovascular (CV) disease (CVD).
Literature was reviewed regarding data from studies and meta-analyses examining the impact of emotional stress on the occurrence and outcome of several CVDs (coronary disease, heart failure, hypertension, arrhythmias, stroke). These influences' pathophysiology and clinical spectrum are detailed, tabulated, and pictorially illustrated.
This type of stress is a newly recognized risk and prognosticator for CVD including coronary artery disease, heart failure, hypertension, cardiac arrhythmias, and stroke, independently of conventional risk factors. It can impact CV outcomes, and also affect health care utilization, with more patient visits to health care facilities. The biological systems activated by mental stress comprise the sympathetic nervous system (SNS), the renin-angiotensin system (RAS), and the hypothalamic- pituitary-adrenal (HPA) axis, while several other biological processes are disrupted, such as endothelial function, inflammatory responses, oxidative stress, mitochondrial function and the function of the amygdala which is the central nervous system processing center of emotions and emotional reactions.
Emotional stress that aggravates symptoms of depression, anxiety, and/or perceived mental stress is common in patients with chronic diseases, such as CVD. It is a newly recognized risk and prognosticator for several CVDs. It can influence CV outcomes, and also affect health care utilization. The biological systems activated by mental stress comprise the SNS, the RAS, and the HPA axis, while several other biological processes are disrupted.
引言/目的:情绪、精神或心理困扰,定义为抑郁、焦虑和/或压力症状增加,在患有慢性疾病(如心血管疾病)的患者中很常见。
回顾了有关研究和荟萃分析数据的文献,这些研究和分析探讨了情绪压力对几种心血管疾病(冠心病、心力衰竭、高血压、心律失常、中风)的发生和结局的影响。详细列出了这些影响的病理生理学和临床范围,并以表格和图片形式进行说明。
这种类型的压力是一种新认识到的心血管疾病(包括冠状动脉疾病、心力衰竭、高血压、心律失常和中风)的风险因素和预后指标,独立于传统风险因素。它会影响心血管结局,还会影响医疗保健的利用情况,患者会增加前往医疗机构就诊的次数。精神压力激活的生物系统包括交感神经系统(SNS)、肾素-血管紧张素系统(RAS)和下丘脑-垂体-肾上腺(HPA)轴,同时其他一些生物过程也会受到干扰,如内皮功能、炎症反应、氧化应激、线粒体功能以及杏仁核的功能,杏仁核是情绪和情绪反应的中枢神经系统处理中心。
加重抑郁、焦虑和/或感知到的精神压力症状的情绪压力在患有慢性疾病(如心血管疾病)的患者中很常见。它是几种心血管疾病新认识到的风险因素和预后指标。它会影响心血管结局,还会影响医疗保健的利用情况。精神压力激活的生物系统包括交感神经系统、肾素-血管紧张素系统和下丘脑-垂体-肾上腺轴,同时其他一些生物过程也会受到干扰。